Program 2019
| Thursday | Thursday November 28th |
|---|---|
| 09.00-09.50 | Registration |
| 09.50-10.00 | Welcoming and opening of the meeting |
| 10.00-12.20 | Session 1 – Parallel sessions You can find a detailed description of each session here |
| Room A | The success of Nordic collaboration – lessons from PSC Moderator: Einar Bjørnsson -Is PSC still the black box of Hepatology? What is new in research on etiology? - Espen Melum, Norway. -Diagnosis and follow-up of patients diagnosed with PSC - Martti Färkkila, Finland -Management of complications of PSC - Annika Bergquist, Sweden |
| Room B | Advanced topics in IBD Care Moderator: Susanna Jäghult Speakers: Randi Opheim, Lars-Petter Jelsness, one more TBD |
| Room C | Hot topics in IBD surgery Moderator: Tom Øresland Speakers: Christianne Buskens, Anthony de Buck van Overstraeten, Anders Tøttrup, Hans Wasmuth |
| 12.00-13.00 | Lunch and posterwalk Moderators Bjørn Moum and Taina Sipponen |
| 13.00-14.00 | MDT/Consultants Corner 1 Ebbe Langholz, Nordic and international panel |
| Session 1 Moderators: Einar Bjørnsson and Hans Strid |
|
| 14.00-14.20 | Biomarkers playing a different role in the future Jonas Halfvarson |
| 14.30-15.00 | Coffe break |
| 15.00-15.20 | Towards personalized anti –TNF in Crohn’s disease; lessons from the PANTS cohort Tariq Ahmad |
| 15.30-15.50 | Treat to target, but what’s the target? Gert D’Haens |
| 16.00 | Oral presentation of 5 selected posters Moderator: Tom Øresland |
| 16.50-17.35 | Satellite Symposium 1 -Janssen New treatments on the horizon for ulcerative colitis Föreläsare 1: Michael Eberhardson, Karolinska sjukhuset Föreläsare 2: Pia Munkhorm, nordsjællands hospital |
| 17.40 - 18.25 | Satellite Symposium 2 -Takeda |
| 18.25 | Adjourn & Mingle |
| 20.00 | Dinner at the Hotel |
| Friday November 29th | |
|---|---|
| 08.00-08.40 | Satellite Symposium 3 - Tillotts Pharma Mesalazine in the biologic era |
| 08.45-09.40 | Satellite Symposium 4 -Pfizer |
| 09.45 | Session 2 Moderators: Jonas Halfvarson and Bjørn Moum |
| 09.45-10.00 | How to interpret pharma studies Jan Marsal |
| 10.10-10.30 | Coffee Break |
| 10.30 | Immune mediated disease and extraintestinal manifestations Tandem talk 1 Checkpoint inhibitors and colitis Michael Eberhardson and Jakob Seidelin |
| 11.05-11.25 | New drugs – new targets, losers and winners Tim Raine |
| 11.35-11.50 | Therapeutic drug monitoring in clinical practice Casper Steenholdt |
| 12.00-12.50 | Lunch |
| 12.50 | Session 3 moderators: Mattias Block and Michael Eberhardson |
| 12.50-13.10 | Fibrosis in Crohn’s disease Gerhard Rogler |
| 13.20-13.35 | Quality Standards of Care Susanna Jäghult |
| 13.45 | MDT/Consultants corner 2 Taina Sipponen, Nordic and international panel: Tom Øresland, Jonas Halfvarsson, Bjørn Moum and Gerhard Rogler |
| 14.55-15.15 | Coffee Break |
| 15.15 | Session 4 Moderators: Susanna Jäghult and Taina Sipponen |
| 15.15-15.55 | Tandem talk 2 Thiopurines pro – con debate Pro: Jørn Brynskov, Con: Paulina Molander |
| 15.55 | Best poster award |
| 16.00 | Adjourn Tom Øresland |